↓ Skip to main content

Dove Medical Press

Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels?

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, June 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
111 Mendeley
Title
Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels?
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, June 2020
DOI 10.2147/dmso.s237454
Pubmed ID
Authors

Michael Wakeman, David T Archer

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 15%
Student > Bachelor 12 11%
Researcher 9 8%
Student > Ph. D. Student 6 5%
Other 5 5%
Other 17 15%
Unknown 45 41%
Readers by discipline Count As %
Medicine and Dentistry 22 20%
Nursing and Health Professions 15 14%
Biochemistry, Genetics and Molecular Biology 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Agricultural and Biological Sciences 2 2%
Other 11 10%
Unknown 48 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2020.
All research outputs
#7,068,524
of 25,584,565 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#283
of 1,182 outputs
Outputs of similar age
#151,562
of 433,829 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#16
of 49 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,182 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,829 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.